🔎 Trials Near Me

Akèy › Dyabèt › North Carolina

Etid klinik pou Dyabèt nan North Carolina

24 etid pou Dyabèt ap chèche patisipan nan sit nan North Carolina.

Vil nan North Carolina

Tèks ofisyèl etid la (Anglè)

Role of Alpha-to-beta Cell Communication to Adapt Insulin Secretion to Insulin Resistance.

  • Duke Center for Living, Durham
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 60 · Tout sèks · Mizajou Oct 1, 2026 · NCT07224334

FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)

  • University of North Carolina at Chapel Hill, Chapel Hill
Ap rekrite
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT06724406

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

  • Medication Management, LLC, Greensboro
  • Accellacare - Wilmington, Wilmington
  • Jeffrey Coleman, OD, Wilmington
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07595549

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  • Metrolina Nephrology Associates, PA, Charlotte
  • Durham Nephrology Associates, PA, Durham
  • Duke Translational Medicine Institute, Durham
  • ak 3 plis
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05485961

Personalized Environment and Genes Study

  • University of North Carolina, Chapel Hill
  • NIEHS Clinical Research Unit (CRU), Research Triangle Park
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 120 · Tout sèks · Mizajou Sep 16, 2026 · NCT00341237

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

  • Duke University, Durham
  • Physicians East, PA, Greenville
  • Wake Research - Raleigh, Raleigh
  • ak 1 plis
Ap rekriteFaz 1/2
Laj 12 a 35 · Tout sèks · Mizajou Sep 11, 2026 · NCT06783309

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

  • Kailera Clinical Site, Greensboro
  • Kailera Clinical Site, Monroe
  • Kailera Clinical Site, Morehead City
  • ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07284901

Evaluating the Efficacy of Perinatal Membrane Allografts in Addition to the Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers.

  • Monroe Biomedical Research, Monroe
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06437028

Integrating New Skills Into Diabetes Education With CGM

  • University of North Carolina at Chapel Hill, Chapel Hill
Ap rekrite
Laj 65 ak plis · Tout sèks · Mizajou Aug 14, 2026 · NCT07463209

Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes

  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Ap rekriteVolontè an sante akeyi
Laj 18 a 99 · Tout sèks · Mizajou Aug 10, 2026 · NCT07061652

Telehealth Music Therapy for Adults With Endocrine Disorder and Depression

  • Appalachian State University, Boone
Ap rekrite
Laj 18 a 65 · Tout sèks · Mizajou Jul 30, 2026 · NCT07413874

CGM for Management of Type 2 Diabetes in Pregnancy

  • University of North Carolina - Chapel Hill, Chapel Hill
Ap rekrite
Laj 18 a 50 · Fanm · Mizajou Jun 29, 2026 · NCT06628453

DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes

  • Wake Forest University, Winston-Salem
Ap rekriteFaz 4
Laj 18 ak plis · Fanm · Mizajou Jun 25, 2026 · NCT06445946

SPYRAL GEMINI Pilot Study

  • University of North Carolina (UNC) Memorial Hospital, Chapel Hill
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Jun 24, 2026 · NCT06907147

The Treatment of Painful Diabetic Neuropathy With Diet

  • AdventHealth Hendersonville, Hendersonville
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Apr 30, 2026 · NCT07509671

Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial

  • Atrium Health, Concord
Ap rekrite
Laj 18 a 84 · Tout sèks · Mizajou Apr 13, 2026 · NCT06190717

NDPP-NextGen: A Clinical Trial to Reduce Intergenerational Obesity and Diabetes Risks

  • Wake Forest University Health Sciences, Winston-Salem
Ap rekriteVolontè an sante akeyi
Laj 18 a 39 · Fanm · Mizajou Feb 27, 2026 · NCT05674799

Transformative Research in Diabetic Nephropathy

  • University of North Carolina, Chapel Hill
Ap rekriteEtid obsèvasyon
Laj 18 a 100 · Tout sèks · Mizajou Feb 27, 2026 · NCT02986984

Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)

  • Atrium Health Wake Forest Baptist (Wake Forest Baptist), Winston-Salem
Ap rekriteEtid obsèvasyon
Laj 12 ak plis · Tout sèks · Mizajou Feb 10, 2026 · NCT06837181

Assessment of AI Program 'DRISTi' as a Screening Tool

  • New Century Ophthalmology - Oxford, Oxford
  • New Century Ophthalmology - Raleigh, Raleigh
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 21 ak plis · Tout sèks · Mizajou Dec 9, 2025 · NCT07222293

Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes: A Pragmatic SMART

  • University of North Carolina at Chapel Hill, Chapel Hill
Ap rekrite
Laj 30 ak plis · Tout sèks · Mizajou Oct 29, 2025 · NCT06405373

Rare and Atypical Diabetes Network

  • University of North Carolina at Chapel Hill, Chapel Hill
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Aug 14, 2025 · NCT05544266

Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers

  • Foot and Ankle Specialists of the Mid-Atlantic, Raleigh
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Feb 10, 2025 · NCT06681428

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.